New Research Shows NEPHROCHECK Test Predicts Acute Kidney Injury Risk For Transaortic Valve Implant Patients
laboratorynetwork.com
Astute Medical, Inc., developer of biomarkers for better healthcare, today said that newly published findings show that the Company's NEPHROCHECK Test may help physicians identify risk of a serious complication in patients who have undergone transcatheter aortic valve implantation (TAVI; also called TAVR, transcatheter aortic value replacement).
Related Stories
Related Books
